Meet Your Medical Team: Social Workers
Erin Charla Peterson, LCSW, is Senior Social Work Counselor at The University of Texas MD Anderson Cancer Center. She is a Licensed Clinical Social Worker who provides counseling
Erin Charla Peterson, LCSW, is Senior Social Work Counselor at The University of Texas MD Anderson Cancer Center. She is a Licensed Clinical Social Worker who provides counseling
Brett Bade, MD, is a pulmonologist at Yale University and the West Haven Veterans Affairs Medical Center. He has board certifications in Internal Medicine, Pulmonology, and
In recent years, immunotherapy, a treatment that enhances the body’s own immune cancer-fighting response, has been shown to be a very promising treatment option. Immunotherapy has
Since the discovery of the first epidermal growth factor receptor (EGFR) mutation in lung cancer in 2004, targeted therapies and immunotherapies have become a major component of
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, comprising 85% of all diagnosed cases of lung cancer. Treatment of NSCLC is dependent on the stage of the
In 2004, after the discovery of mutations in the EGFR gene in lung cancer, the FDA approved a targeted therapy that increased survival in EGFR-positive NSCLC patients. However, the
Small cell lung cancer (SCLC) accounts for about 15% of all lung cancers and is found most often in people with a history of tobacco exposure. Patients with late-stage SCLC often
Dr. Joshua Campbell has been immersed in the field of lung cancer for several years and wanted to find a better way to diagnose squamous cell lung cancer patients, a subtype of non
A newly diagnosed patient with advanced-stage adenocarcinoma, a sub-type of non-small cell lung cancer (NSCLC), may have their biopsy tissue tested for known biomarkers. The
Many people with family histories of cancer are getting tested to identify their cancer risk and take action before it starts. For example, the actress Angelina Jolie, who
I am sure all of you have heard the phrase “ A picture’s worth a thousand words!” I first heard it from my undergraduate biology professor, who always reminded us that each time we
Alice Shaw, MD, PhD, is a world-class thoracic oncologist at Massachusetts General Hospital and Harvard Medical School who focuses her research and her clinical practice on